Work

A phase II trial of irinotecan in hormone-refractory prostate cancer

Year: 1998

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1023/a:1006120910380

Authors: David M. Reese, Simon Tchekmedyian, Yvonne Chapman, Diane Prager, Peter J. Rosen

Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W113626925

FWCI: 0.137

Cites: 19

Cited by: 18

Related to: 10